Adenine arabinoside in severe thrombocytopenia due to hemorrhagic varicella

Dan Aderka, Meir Djaldetti, Chorlotte Sharon, Fransis Salomon, Abraham Weinberger, Jack Pinkhas*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


An 18-year-old man, admitted because of severe bleeding manifestations due to varicella thrombocytopenia was administered 800 mg/day adenine arabinoside (Ara-A) intravenously for 5 days. 2 days after the start of this treatment the bleeding phenomena became markedly reduced and a progressive increase in the platelet count was noted thereafter. Although a spontaneous improvement is known to occur in patients with varicella thrombocytopenia, the rapid clinical improvement after the Ara-A administration is suggestive for its beneficial effect in the presented patient.

Original languageEnglish
Pages (from-to)280-284
Number of pages5
JournalActa Haematologica
Issue number4
StatePublished - 1984


  • Adenine arabinoside
  • Hemorrhagic varicella
  • Thrombocytopenia


Dive into the research topics of 'Adenine arabinoside in severe thrombocytopenia due to hemorrhagic varicella'. Together they form a unique fingerprint.

Cite this